Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis

American Journal of Physical Medicine and Rehabilitation

Volumn 87, Issue 4, 2008, Pages 321-324

  Meijer, Jan Willem G ^a,b,d   Van Kuijk, Annet A ^a,c   Geurts, Alexander C H ^c   Schelhaas, H Jurgen ^c   Zwarts, Machiel J ^c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amyotrophic Lateral Sclerosis; Botulinum Toxin; Complication; Sialorrhoea

Indexed keywords

BOTULINUM TOXIN A; MACROGOL 10000;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANARTHRIA; APHAGIA; ARTICLE; CASE REPORT; CATHETER; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERSALIVATION; MOTOR PERFORMANCE; NOSE FEEDING; SCORING SYSTEM; SPEECH DISORDER; TREATMENT OUTCOME; ULTRASOUND;

AMYOTROPHIC LATERAL SCLEROSIS; APNEA; BOTULINUM TOXIN TYPE A; DEGLUTITION DISORDERS; FATAL OUTCOME; FEMALE; HUMANS; INJECTIONS; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAROTID GLAND; SIALORRHEA; SUBMANDIBULAR GLAND;

EID: 41349114075     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e318164a931     Document Type: Article

References (18)

1. Bushara KO: Sialorrhoea in amyotrophic lateral sclerosis: a hypothesis of a new treatment; botulinum toxin A injections of the parotid glands. Med Hypotheses 1997;48:337-9
2. Giess R, Naumann M, Werner E, et al: Injection of botulinum toxin A into the salivary glands improves sialorrhoea in amyothrophioc lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-3
3. Porta M, Gamba M, Bertachi G: Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538-40
4. Hiller AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N: Amyotrophic Lateral Sclerosis Severity Scale. Neuroepidemiology 1989;8:142-50
5. Tan EK, Lo YL, Seah A, Auchus AP: Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. J Neurol Sci 2001;190:95-7
6. Winterholler MGM, Erbguth FJ, Wolf S, Kat S: Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. J Neurol Neurosurg Psychiatry 2001;70:417-8
7. Naumann M, Giess R, Schwager K, Toyka KV: Authors reply. J Neurol Neurosurg Psychiatry 2001;70:419
8. Contarino MF, Pompili M, Tittito P, et al: Botulinum toxin B ultrasound guided injections in sialorrhoea in amyotrophic lateral sclerosis and Parkinson's disease. Parkinsonism Relat Disord 2007;13:299-303
9. Gioltzoglou T, Cordivari C, Lee PJ, Hanna MG, Lees AJ: Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature. J Neurol Neurosurg Psychiatry 2005;76:1594-6
10. Manrique D: Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis. Rev Bras Otorinolaringol 2005;71:566-9
11. Verma A, Steele J: Botulinum toxin improves sialorrhoea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve 2006;34:235-7
12. Nussgens Z, Roggenkamper P: Comparison of two botulinum toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 1997;235:197-9
13. Bihari K: Safety, effectiveness, and duration of effect of Botox after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm. Curr Med Res Opin 2005;21:433-8
14. Dogu O, Apaydin D, Sevim S, Talas DU, Aral M: Ultrasound-guided versus blind intraparotid injections of botulinum toxin A for the treatment of sialorrhoea in patients with Parkinson disease. Clin Neurol Neursurg 2004;106:93-6
15. Hsu TS, Dover JS, Arndt KA: Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 2004;140:1351-4
16. Forshew DA, Bromberg MB: A survey of clinicians' practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:258-63
17. Andersen PM, Gronberg H, Franzen L, Funegard U: External radiation of the parotid glands significantly reduces drooling in patients with motor neuron disease with bulbar paresis. J Neurol Sci 2001;191:11-4
18. Harriman M, Morrison M, Hay J, Revonta M, Eisen A, Lentle B: Use of radiotherapy for control of sialorrhoea in patients with amyotrophic lateral sclerosis. J Otolaryngol 2001;30:242-5